Commercialization And Logistics
-
A Robust, Future-Ready Solution That Adapts To Your Needs
5/22/2025
Explore a future-ready solution that features advanced automation, intuitive design, and scalable solutions to streamline your bioprocessing workflows and prepare your operations for future growth.
-
Uninstalling CTS Dynacellect Bead Removal Kit
6/9/2025
A detailed walkthrough on how to uninstall the Gibco CTS DynaCellect Bead Removal Kit when the bead removal protocol or the Gibco CTS DynaCellect magnetic separation system is completed.
-
Scaling Viral Vectors
11/13/2023
Industry experts cover the high operational costs associated with viral vectors, along with the challenge presented by their shot shelf life and scalability.
-
Perfusion: Medium Selection And Testing
6/16/2025
An examination of what to consider in a perfusion medium, including varying reconstituted concentrations, supporting multiple cell clones, allowing for high cell densities at low medium exchange rates, and using it in various types of perfusion.
-
Thermo Fisher Scientific Bio-Expo Live 2024: Downstream Bioprocessing
8/15/2024
Review downstream process tools from Thermo Fisher Scientific to enable optimal biologics purification, including chromatography resins, chemicals, process liquids, and buffers.
-
AAV Downstream Challenges: Expert Insights
5/22/2025
Gain expert insight into the complexities of AAV purification to learn how industry leaders tackle downstream challenges, optimize workflows, and drive innovation in scalable, efficient gene therapy manufacturing solutions.
-
Planning for Success: Supply Resiliency Strategies for Bench to Production
10/18/2023
Build scalable material sourcing strategies for R&D and early phases through to commercialization and learn how to accelerate the development process and ensure the scalability of your biologics.
-
Cell Therapy Bioprocessing Workflow Cinematic
5/28/2025
Witness a seamless cell therapy bioprocessing workflow that reduces manufacturing time and preserves the crucial cell phenotype for scalable, effective autologous and allogeneic therapies.
-
Quality Control Assays
11/13/2023
Two company leaders detail not only the vectors their respective companies use and why but also the quality control assays performed on viral vectors.
-
Improvements In Scaling And Sequencing For Allogeneic Cell Therapies For Oncology
5/6/2024
During this segment, Nguyen and Wagner agree that scalability will be a top concern for most CGT companies.